Boulevard Bio Secures $65 Million and Unveils Positive Data for Lead Candidate

Boulevard Bio emerges with a significant investment and encouraging early Phase 1 results for BLVD101.

AI-assisted, human-published

Latest headlines

Join us for funding and investment opportunities.

Stay connected!

If you have a serious, bonafide inquiry into the VentureCapital.com or PrivateEquity.com domain names, please contact us here